“In patients who are at higher risk of complications from open-heart surgery, minimally invasive procedures known as percutaneous transcatheter interventions are preferred,” said Ammar Hasnie, M.D., a ...
The Society for Cardiovascular Angiography & Interventions (SCAI) has published a comprehensive roadmap that details the use of intracardiac echocardiography (ICE) to guide structural heart disease ...
WASHINGTON—The Society for Cardiovascular Angiography & Interventions (SCAI) has published a comprehensive roadmap that details the use of intracardiac echocardiography (ICE) to guide structural heart ...
Over the past year, interventions for aortic, mitral, and tricuspid valve disease have dominated headlines in structural heart disease news. Some of the most impactful studies were those providing ...
The FULCRUM-VT trial evaluated the clinical utility of ultra-low temperature ablation for treating ventricular tachycardia in ...
Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR), a global structural heart company committed to designing, ...
NEW YORK – April 4, 2024 – The Cardiovascular Research Foundation ® (CRF ®) is excited to introduce New York Valves: The Structural Heart Summit, the expanded next iteration of our renowned annual ...
GENT, Belgium--(BUSINESS WIRE)--FEops announced today its new release of FEops HEARTguide™, including an AI-based anatomical analysis of MSCT images for the pre-operative planning of structural heart ...
GENT, Belgium--(BUSINESS WIRE)--FEops, a leader in personalized predictive planning for structural heart interventions, announced today its partnership with ConcertAI's TeraRecon, for the ...
Professional societies laid out the roadmap to advanced training in interventional cardiology for the first time in a comprehensive statement of requirements. The American College of Cardiology (ACC), ...
“Structural heart disease” is an umbrella term that refers to conditions that affect different structures within the heart. Some of these problems can be present at birth, while others develop later ...
In the year of TAVI’s big anniversary (TAVITurnsTwenty; 26 Down), one of the most-awaited trials presented at TCT 2022 was PROTECTEDTAVR (3 Down), which missed its primary endpoint by failing to show ...